Urologic nursing : official journal of the American Urological Association Allied 2013-01-01

Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer.

Neal D Shore, Paul Sieber, Leanne Schimke, Adam Perzin, Scott Olsen

Index: Urol. Nurs. 33(5) , 236-44, 248, (2013)

Full Text: HTML

Abstract

This multicenter, randomized, crossover, open-label study (ClinicalTrials.gov identifier: NCT01161563) assessed patients'and clinicians'perceptions of injection site tolerability and adverse events following the intramuscular injection of triptorelin pamoate or subcutaneous injection of leuprolide acetate in 107 male, patients with advanced prostate cancer.